271 related articles for article (PubMed ID: 11254748)
1. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol.
Björkhem I; Starck L; Andersson U; Lütjohann D; von Bahr S; Pikuleva I; Babiker A; Diczfalusy U
J Lipid Res; 2001 Mar; 42(3):366-71. PubMed ID: 11254748
[TBL] [Abstract][Full Text] [Related]
2. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
3. 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway.
Wassif CA; Yu J; Cui J; Porter FD; Javitt NB
Steroids; 2003 Aug; 68(6):497-502. PubMed ID: 12906934
[TBL] [Abstract][Full Text] [Related]
4. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1.
Goyal S; Xiao Y; Porter NA; Xu L; Guengerich FP
J Lipid Res; 2014 Sep; 55(9):1933-43. PubMed ID: 25017465
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
[TBL] [Abstract][Full Text] [Related]
7. Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice.
Meaney S; Lütjohann D; Diczfalusy U; Björkhem I
Biochim Biophys Acta; 2000 Jul; 1486(2-3):293-8. PubMed ID: 10903480
[TBL] [Abstract][Full Text] [Related]
8. On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO.
Björkhem I; Diczfalusy U; Lövgren-Sandblom A; Starck L; Jonsson M; Tallman K; Schirmer H; Ousager LB; Crick PJ; Wang Y; Griffiths WJ; Guengerich FP
J Lipid Res; 2014 Jun; 55(6):1165-72. PubMed ID: 24771866
[TBL] [Abstract][Full Text] [Related]
9. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls in measuring plasma cholesterol in the Smith-Lemli-Opitz syndrome.
Jira PE; de Jong JG; Janssen-Zijlstra FS; Wendel U; Wevers RA
Clin Chem; 1997 Jan; 43(1):129-33. PubMed ID: 8990234
[TBL] [Abstract][Full Text] [Related]
11. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts.
Honda M; Tint GS; Honda A; Nguyen LB; Chen TS; Shefer S
J Lipid Res; 1998 Mar; 39(3):647-57. PubMed ID: 9548596
[TBL] [Abstract][Full Text] [Related]
12. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome.
Batta AK; Salen G; Tint GS; Shefer S
J Lipid Res; 1995 Nov; 36(11):2413-8. PubMed ID: 8656079
[TBL] [Abstract][Full Text] [Related]
13. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
[TBL] [Abstract][Full Text] [Related]
14. [Historical aspects of the Smith-Lemli-Opitz syndrome].
Bzdúch V; Behúlová D; Skodová J; Skokňová M; Kozák L
Cas Lek Cesk; 2014; 153(1):36-9. PubMed ID: 24506692
[TBL] [Abstract][Full Text] [Related]
15. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
Holdenrieder S; Lütjohann D; Geiger S; von Bergmann K; Stieber P; Hamann GF
Neurosci Lett; 2004 Sep; 368(2):201-4. PubMed ID: 15351449
[TBL] [Abstract][Full Text] [Related]
16. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse.
Meljon A; Wang Y; Griffiths WJ
Biochem Biophys Res Commun; 2014 Apr; 446(3):768-74. PubMed ID: 24491562
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical diagnosis of Smith-Lemli-Opitz syndrome in a patient with congenital adrenal hyperplasia].
GarcíaFuentes E; icioso Recio MV ; del Castillo Acedo Del Olmo E ; atas Jurado MM ; Arana Agüera M ; López López J
An Esp Pediatr; 2000 Nov; 53(5):482-7. PubMed ID: 11141372
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface.
Bretillon L; Lütjohann D; Ståhle L; Widhe T; Bindl L; Eggertsen G; Diczfalusy U; Björkhem I
J Lipid Res; 2000 May; 41(5):840-5. PubMed ID: 10787445
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation.
Björkhem I; Lütjohann D; Diczfalusy U; Ståhle L; Ahlborg G; Wahren J
J Lipid Res; 1998 Aug; 39(8):1594-600. PubMed ID: 9717719
[TBL] [Abstract][Full Text] [Related]
20. 24-hydroxycholesterol is a substrate for hepatic cholesterol 7alpha-hydroxylase (CYP7A).
Norlin M; Toll A; Björkhem I; Wikvall K
J Lipid Res; 2000 Oct; 41(10):1629-39. PubMed ID: 11013305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
